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Abstract: Invasive aspergillosis is often lethal
in transplant recipients. The mortality
associated with this disease after organ
transplantation approaches 100%, partly
because it is difficult to recognize and
diagnose early on. The clinical course and
histological findings in invasive pulmonary
aspergillosis in immunocompromised hosts
differ from those seen in patients who
develop
classic
aspergillomas.
In
immunosuppressed patients, the predominant
pathologic abnormalities are tissue invasion,
abscess formation, and angioinvasion with or
without infarction.
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Introduction
Invasive aspergillosis is a well-known serious
complication of organ transplantation (1-3). Research has
identified several risk factors for invasive Aspergillus spp.
infection in transplant recipients, including treatment
with high-dose corticosteroids, OKT3 therapy,
retransplantation, multiple abdominal operations,
prolonged surgery, high serum creatinine levels and
cytomegalovirus (CMV) infection (4-5).
Although Aspergillus can be isolated from patients’
respiratory secretions, diagnosis of invasive disease
requires histopathologic confirmation, and a definitive
diagnosis can only be established through
immunochemical studies (6). In this report, we describe
the various histopathologic features of invasive
pulmonary aspergillosis in one kidney recipient and three
liver transplant recipients, and underline the differences
between this form of the disease and classic
aspergillomas. Two autopsies and two postmortem
biopsies are discussed.

Case Descriptions
All four of the infected recipients were male, and their
mean age was 41 years. Some of the clinical features of

In this study, we examined cases of invasive
pulmonary aspergillosis in one kidney
recipient and three liver transplant recipients.
All the patients were male, and their mean age
was 41 years. The mean time to onset of
infection was 37 days after transplantation.
We discuss the pathologic findings of
angioinvasion, infarction and bronchial
invasion that were observed in these
immunosuppressed individuals.
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each case are summarized in the Table. The patients had
been on various antibiotics within a month of the onset of
aspergillosis infection. They were also taking cyclosporine
A and prednisone as part of the standard posttransplantation protocol, but none of the four had been
treated with OKT3. The mean time to onset of infection
was 37 days after transplantation.
Invasive pulmonary aspergillosis was tentatively
diagnosed at autopsy in two of the liver recipient cases,
and by postmortem needle biopsy in the other two
patients. One patient was diagnosed with disseminated
invasive pulmonary aspergillosis, in which the lung,
kidney and transplanted liver were affected. None of the
cases featured any CMV infection-related histopathologic
findings.
In both of the liver recipient cases diagnosed at
autopsy, we found that the lungs were heavier than
normal (normal: 350-425 g).
Gross examination of the lungs revealed consolidation
and lobar pneumonia with red hepatization. The tissue
had a granular texture, and contained white nodular
lesions of variable size. These lesions were most striking
at the base of the lung lobes, and some were hemorrhagic
(Figure 1). The trachea and bronchi also showed
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Table.

Case

Gender

Age (Years)

Renal or Liver tx

Etiology

1
2
3
4

M
M
M
M

45
53
24
42

Renal
Liver
Liver
Liver

Nephrolithiasis
HCV* + Chronic Hepatitis
Wilson’s Disease
HBV** + End Stage Liver Disease

Patient clinical features.

*HCV- Hepatitis C virus
**HBV- Hepatitis B virus

deparaffinized and then stained with hematoxylin-eosin,
methanamine silver and periodic acid-Schiff (PAS).

Figure 1.

Gross examination of the lungs.

hemorrhage and mucosal erosions. The kidneys in both of
these patients contained numerous well-demarcated
lesions with distinct borders. The center of these lesions
was white-yellow, and the periphery was bright red
(Figure 2).

Microscopic examination of the autopsy sections of
lung, kidney and graft liver revealed numerous nodules
filled with masses of hyphae. Some of the hyphal masses
showed central necrosis. Typical of Aspergillus spp., the
hyphae were uniform in size, narrow, septate and
basophilic. Necrotic hyphae were often eosinophilic. The
hyphal branches tended to arise at 45° angles.
Characteristic hyphal morphology was demonstrated
better with methanamine silver and PAS stains than with
hematoxylin-eosin (Figures 3-4). In addition to the
nodules, the specimens showed suppurative inflammatory
infiltrate, parenchymal hemorrhage and tissue necrosis,
and the hyphae were invading the walls of the veins and
the bronchi. One patient’s kidney showed microabscess
formation.

Figure 3.

Figure 2.

Gross examination of the kidney.

All specimens were fixed in 10% formaldehyde and
embedded in paraffin. The tissue blocks were cut in serial
4-5 µm-thick sections, and the sections were
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Characteristic hyphal morphology (PAS X 100).

In the two cases diagnosed by postmortem needle
biopsy, specimens of liver, lung and kidney were collected
from the kidney recipient, and samples of spleen, lung,
liver, kidney and bone marrow were collected from the
liver recipient. In both these patients, only the lungs
showed typical Aspergillus hyphal morphology.
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Figure 4.

Characteristic hyphal morphology (Methanamine Silver X
100).

Discussion
Invasive aspergillosis is an opportunistic infection that
occurs almost exclusively in immunosuppressed and
debilitated hosts. Aspergillus fumigatus is the species
most often isolated from patients with invasive or
disseminated infection. The clinical findings in invasive
pulmonary aspergillosis are non-specific. Sputum cultures
yield growth in only about one-third of cases (7). The
diagnosis is usually made based on the detection of typical
Aspergillus hyphae, the invading form of the fungus, in
tissue specimens collected at postmortem examination (68-9-10).
The clinical course and histological findings in invasive
pulmonary aspergillosis in immunocompromised hosts
are different from those seen in patients who develop
classic aspergillomas (11). Colonizing aspergillosis, or
aspergilloma, implies growth of the fungus in pulmonary
cavities with minimal or no invasion of the tissues. In
these classic cases, cavities generally form where there
are pre-existing lesions. Proliferation at these sites
produces free masses of hyphae inside the cavities. The
surrounding inflammatory reaction may be mild, or there
may be chronic inflammation and fibrosis (7).
In contrast, in invasive forms of the infection, the
predominant pathologic abnormalities are tissue invasion,
abscess formation, and angioinvasion with or without
infarction (12); thus, the examiner usually sees areas of
hemorrhage and infarction superimposed on the
necrotizing inflammatory tissue reactions (7). Although
the finding of typical hyphae is generally diagnostic, other
types of septate hyphae seen in tissue sections can be

mistaken for Aspergillus spp. These fungi include
Pseudallescheria boydii, Fusarium spp. and other
opportunistic hyalohyphomycetes, and Candida spp.
Recognizing and checking for the subtle differences in the
morphology of these different fungi may help distinguish
them from aspergilli. Histopathologic diagnosis of
aspergillosis must be considered presumptive unless
confirmed by immonohistochemistry or by microbiologic
isolation of Aspergillus (13). Studies have shown that
histopathologic demonstration of hyphal invasion of
blood vessels or tissue is associated with poor prognosis
(14). All four of our cases exhibited diffuse vascular and
bronchial invasion with necrosis.
Disseminated invasive aspergillosis is defined as
involvement of two or more non-contiguous organ sites
(4). In mice with disseminated aspergillosis, T helperdependent lung mucosal immunity plays an essential role
in host defense against invasive pulmonary aspergillosis
(15). The primary host defense against dissemination of
Aspergillus organisms is professional phagocytes.
However, immunosuppressive regimens that prescribe
corticosteroids tend to seriously impair phagocytic
activity, even in the absence of overt granulocytopenia
(1). One of our patients had the disseminated form of the
disease, which, in this case, was characterized by lung,
kidney and graft liver involvement. In addition to hyphal
invasion of tissues and necrosis, this patient’s kidneys
contained many microabscesses.

Aspergillus organisms are capable of penetrating any
host tissue. Secretory proteinases produced by the fungus
can facilitate hyphal destruction of fibrillar proteins such
as elastin and collagen, but these enzymes may only be of
minor importance in the pathogenesis of invasive
aspergillosis. One report stated that microscopic
examination of aspergilli penetrating vessel walls showed
no obvious lysis of wall proteins, thus emphasizing the
importance of mechanical disruption of fibrillar proteins
by the growing hyphae (16). If elastolysis contributes at
all to the invasion of vessel walls by aspergilli, then it
seems to be very localized and/or transient in nature (17).
In the lungs of immunosuppressive patients, infection
rapidly becomes systemic when there is tissue necrosis
and hemorrhage related to vascular invasion. Aspergillus
lesions tend to be distributed in a generalized pattern in
the lung, but in highly vascular tissues, such as the
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kidney, the lesions are focal and may form
microabscesses. Needle biopsy is less likely to reveal
fungal forms in tissues where disseminated infection
produces focal lesions. In such cases, repeated needle
biopsies are necessary to obtain adequate material for
study.
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